Dozee

A sensor sheet under the mattress captures micro-vibrations from heartbeats, respiration and movement, without wires or electrodes.

Continuous tracking with alerts intended to flag patient deterioration before it becomes critical.

Dozee's proprietary contactless vital signs measurement technology received US FDA 510(k) clearance.

Automates routine vitals collection to save nursing time versus manual monitoring.

Dozee's remote patient monitoring platform is deployed across hospital wards to continuously track patients.

Targets acute and post-acute care settings including SNFs and elder/chronic care ALFs, mainly in the US market.

Contactless monitoring device for home/chronic-care use, tracking sleep and vitals under the mattress.

Dozee provides hands-on training and ongoing support to hospital/facility staff on using the RPM platform to care for patients.

Dozee commits to round-the-clock availability for its provider customers rather than standard business-hours support.

For providers that want a hands-off option, Dozee takes on end-to-end responsibility for patient onboarding and alert management rather than just supplying software.

Dozee's team engages each hospital individually to understand its specific requirements and customizes the solution rather than offering one fixed package.

Direct sales/deployment into hospital wards, scaled from 216 hospitals (2021) to 200+ hospitals cited on its current site.

Expansion into international markets alongside its Indian hospital base.

MillionICU initiative with British International Investment upgrades beds in public hospitals as a distribution channel into government healthcare.

Continued R&D to launch new products and enhance platform capabilities.

Upgrading regular hospital beds to step-down ICU-equivalent monitored beds, including via the MillionICU initiative.

Core contactless sensing hardware plus cloud-based AI algorithms that convert vibration data into vital signs.

Regulatory clearance for its contactless vital signs measurement system, supporting entry into the US market.

Partnership to upgrade thousands of public hospital beds to step-down ICUs using Dozee's monitoring technology.

Dozee was selected as one of the deeptech startups in Jio's JioGenNext accelerator programme.

The Gates Foundation is an investor/backer of Dozee.

Dozee sells contactless patient monitoring systems and an early-warning system to hospitals, letting clinical staff remotely track vitals and receive deterioration alerts.

For home/individual users, the Dozee device is sold outright or offered on a monthly rental plan instead of requiring full upfront purchase.

Employee benefit expenses are Dozee's single biggest cost head. The company cut this spend 12% year-on-year to INR 47 Cr in FY24 from INR 53.3 Cr in FY23 as part of a cost-reduction push.

Total expenditure declined 15% to INR 74.5 Cr in FY24 from INR 87.9 Cr in FY23, narrowing the company's cash burn.

Facing losses driven largely by employee and advertising expenditure, Dozee cut an estimated 40-50 roles across sales, marketing and customer success; the company publicly described it as a 'reallocation of resources' rather than layoffs.